O'Connor Donal

CIK 00016253772 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001625377

Recent Transactions

50 trades

Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2026-06-12+13,398→ 13,398 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2026-06-12+6,009→ 80,213 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Restricted Stock Units
2026-05-14−7,305→ 0 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Ordinary Shares
2026-05-14$10.84/sh+7,305→ 37,942 total
Tax Payment
PERRIGO Co plc$PRGO
Ordinary Shares
2026-05-14$10.84/sh−3,507→ 34,435 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2026-05-13+16,681→ 16,681 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2025-05-19+24,258→ 24,258 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2025-05-19+10,649→ 74,204 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Restricted Stock Units
2025-05-14−9,904→ 0 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Ordinary Shares
2025-05-14$26.01/sh+9,904→ 35,391 total
Tax Payment
PERRIGO Co plc$PRGO
Ordinary Shares
2025-05-14$26.01/sh−4,754→ 30,637 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2025-05-14+7,305→ 7,305 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Ordinary Shares
2024-05-15$30.22/sh+8,764→ 29,694 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Restricted Stock Units
2024-05-15−8,764→ 0 total
Tax Payment
PERRIGO Co plc$PRGO
Ordinary Shares
2024-05-15$30.22/sh−4,207→ 25,487 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2024-05-14+9,904→ 9,904 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2024-05-08+10,537→ 63,555 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2024-05-08+23,576→ 23,576 total
Tax Payment
PERRIGO Co plc$PRGO
Ordinary Shares
2023-05-17$32.86/sh−3,734→ 20,930 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Ordinary Shares
2023-05-17$32.86/sh+7,778→ 24,664 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Restricted Stock Units
2023-05-17−7,778→ 0 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2023-05-15+8,764→ 8,764 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2023-05-02+9,132→ 53,018 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2023-05-02+22,044→ 22,044 total
Disposition to Issuer
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2022-11-22$10.50/sh−10,000→ 43,886 total
Tax Payment
PERRIGO Co plc$PRGO
Ordinary Shares
2022-05-17$38.57/sh−3,168→ 16,886 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Restricted Stock Units
2022-05-17−6,599→ 0 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2022-05-17+7,778→ 7,778 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Ordinary Shares
2022-05-17$38.57/sh+6,599→ 20,054 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2022-04-26+9,852→ 53,886 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2022-04-26+28,000→ 28,000 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2021-05-17+6,599→ 6,599 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Restricted Stock Units
2021-05-07−5,804→ 0 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Ordinary Shares
2021-05-07$42.96/sh+5,804→ 16,241 total
Tax Payment
PERRIGO Co plc$PRGO
Ordinary Shares
2021-05-07$42.96/sh−2,786→ 13,455 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2021-04-27+9,828→ 44,034 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2021-04-27+6,000→ 6,000 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Ordinary Shares
2020-05-15$52.76/sh+6,054→ 13,343 total
Tax Payment
PERRIGO Co plc$PRGO
Ordinary Shares
2020-05-15$52.76/sh−2,906→ 10,437 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Restricted Stock Units
2020-05-15−6,054→ 0 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2020-05-07+5,804→ 5,804 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2020-04-28+6,635→ 34,206 total
Award
Theravance Biopharma, Inc.$TBPH
Share Option (Right to Buy)
2020-04-28+6,000→ 6,000 total
Sale
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2019-05-17$20.19/sh−2,673→ 27,571 total
Sale
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2019-05-16$21.00/sh−1,327→ 30,244 total
Award
PERRIGO Co plc$PRGO
Restricted Stock Units
2019-05-15+6,054→ 6,054 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Restricted Stock Units
2019-05-15−3,971→ 0 total
Exercise/Conversion
PERRIGO Co plc$PRGO
Ordinary Shares
2019-05-15$49.55/sh+3,971→ 9,196 total
Tax Payment
PERRIGO Co plc$PRGO
Ordinary Shares
2019-05-15$49.55/sh−1,907→ 7,289 total
Award
Theravance Biopharma, Inc.$TBPH
Ordinary Shares
2019-04-30+8,385→ 31,571 total

Companies

Recent Filings

Address

C/O THERAVANCE BIOPHARMA US, LLC 901 GATEWAY BLVD

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov